v3.26.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
COMMON
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE GAIN (LOSS)
Beginning Balance (in shares) at Dec. 31, 2023   4,728,674      
Beginning Balance at Dec. 31, 2023 $ 106,184 $ 4 $ 341,410 $ (235,245) $ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from a securities purchase agreement, net of offering costs (in shares)   454,545      
Issuance of common stock from a securities purchase agreement, net of offering costs of $268 5,137   5,137    
Issuance of common stock under the stock purchase plan (in shares)   7,603      
Issuance of common stock under the stock purchase plan 62   62    
Issuance of common stock under the stock award plan   241      
Forfeiture of restricted common stock (in shares)   (2,320)      
Forfeiture of restricted common stock 0        
Share-based compensation 7,993   7,993    
Net loss (57,775)     (57,775)  
Other comprehensive gain 53       53
Ending Balance (in shares) at Dec. 31, 2024   5,188,743      
Ending Balance at Dec. 31, 2024 61,654 $ 4 354,602 (293,020) 68
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from a securities purchase agreement, net of offering costs (in shares)   12,736      
Share-based compensation 1,879   1,879    
Net loss (9,439)     (9,439)  
Other comprehensive gain (21)       (21)
Ending Balance (in shares) at Mar. 31, 2025   5,201,479      
Ending Balance at Mar. 31, 2025 54,073 $ 4 356,481 (302,459) 47
Beginning Balance (in shares) at Dec. 31, 2024   5,188,743      
Beginning Balance at Dec. 31, 2024 61,654 $ 4 354,602 (293,020) 68
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the stock purchase plan (in shares)   7,258      
Issuance of common stock under the stock purchase plan $ 16   16    
Issuance of common stock under the stock award plan 0 87,320      
Share-based compensation $ 5,314   5,314    
Net loss (8,978)     (8,978)  
Other comprehensive gain (50)       (50)
Ending Balance (in shares) at Dec. 31, 2025   5,283,321      
Ending Balance at Dec. 31, 2025 $ 57,956 $ 4 359,932 (301,998) 18
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under the stock purchase plan (in shares)   6,354      
Issuance of common stock under the stock award plan 561 561      
Issuance of common stock under the stock award plan $ 3   3    
Share-based compensation 613   613    
Net loss (8,278)     (8,278)  
Other comprehensive gain (17)       (17)
Ending Balance (in shares) at Mar. 31, 2026   5,290,236      
Ending Balance at Mar. 31, 2026 $ 50,277 $ 4 $ 360,548 $ (310,276) $ 1